SOPHIA ANTIPOLIS, France & LAS VEGAS–(BUSINESS WIRE)–Regulatory News: Median Technologies (FR0011049824, ALMDT, “Median” or the “Company”), developer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer detection and diagnosis, announced today that Eyonis Inc., its U.S. subsidiary has been selected a winner of the 2026 Digital Health Hub Foundation Digital Health & AI Awards. Eyonis was named a “Rising Star” in the “Cancer, Scree